ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626673 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626673; 2) Community: the network communities that were significantly associated with the response to NSC 626673; 3) Molecule: the relationships between components within communities and NSC 626673; 4) MDR: the compounds that were significantly associated with the NSC 626673.

NSC Compound Enrichment Correlation
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0238174255956144 0.46514744
NSC 679828 Null 0.0238174255956144 0.10604129
NSC 683556 Camptothecin Derivative 0.0238174255956144 0.092637762
NSC 685886 Null 0.0238174255956144 -0.14862267
NSC 83950 A 050165L302 0.0238174255956144 -0.077287383
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0238174255956146 0.32380916
NSC 629595 Null 0.0238174255956146 0.33607678
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0238174255956146 0.49397846
NSC 633271 Null 0.0238174255956146 0.3027672
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0238174255956146 0.33057041
Total:145  Current:85    [First] [Prev] [Next] [Last]